新冠疫情时代肾移植与继续等待名单的死亡风险比较
该研究基于1433例终末期肾病患者队列,比较了299例等待名单患者与237例移植后第一年受者的COVID-19感染率和结局。随访68天发现,等待名单患者感染率更高,但移植受者确诊后死亡风险更高(校正后HR=3.36,95%CI 1.19-9.50,P=0.022),两组总体死亡率相当(P=0.69)。
要点
- 等待名单患者COVID-19感染率更高,但移植受者感染后死亡风险更高。
- 两组总体死亡率相当,移植受者确诊后死亡风险校正后HR为3.36。
- 透析患者未检测感染血清阳性率18.3%,移植受者4.6%。
核心结论
- 等待名单患者COVID-19感染更常见,但移植受者感染相关死亡率更高,导致总体死亡率相当。
研究设计与样本
- 回顾性队列研究,纳入1433例终末期肾病患者,分析299例等待名单患者与237例移植后第一年受者,随访68天。
主要发现
- 等待名单与移植受者总体死亡率相当(P=0.69)。
- 等待名单患者COVID-19感染诊断更常见(P=0.001),且更可能接受RT-PCR检测(P=0.0004)。
- 确诊感染后,移植受者死亡风险更高(P=0.015)。
- 透析与移植患者中未检测感染的血清阳性率分别为18.3%和4.6%(P=0.0001)。
- 校正筛查偏倚后,移植受者确诊COVID-19后死亡相对风险仍更高(HR=3.36,95%CI 1.19-9.50,P=0.022)。
临床怎么用
- 在COVID-19流行期,应权衡移植受者感染后高死亡风险与等待名单患者感染风险,个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There are limited data pertaining to comparative outcomes of remaining on dialysis versus kidney transplantation as the threat of coronavirus disease 2019 (COVID-19) remains. In this study we delineate the differential risks involved using serologic methods to help define exposure rates. METHODS: From a cohort of 1433 patients with end-stage kidney disease (ESKD), we analyzed COVID-19 infection rates and outcomes in 299 waitlist patients compared with 237 transplant recipients within their first year post-transplant. Patients were followed over a 68-day period from the time our transplant program closed due to COVID-19. RESULTS: The overall mortality rates in waitlist and transplant populations were equivalent (P = 0.69). However, COVID-19 infection was more commonly diagnosed in the waitlist patients (P = 0.001), who were more likely to be tested by reverse transcriptase polymerase chain reaction (P = 0.0004). Once infection was confirmed, mortality risk was higher in the transplant patients (P = 0.015). The seroprevalence in dialysis and transplant patients with undetected infection was 18.3% and 4.6%, respectively (P = 0.0001). After adjusting for potential screening bias, the relative risk of death after a diagnosis of COVID-19 remained higher in transplant recipients (hazard ratio = 3.36 [95% confidence interval = 1.19-9.50], P = 0.022). CONCLUSIONS: Although COVID-19 infection was more common in the waitlist patients, a higher COVID-19‒associated mortality rate was seen in the transplant recipients, resulting in comparable overall mortality rates.
引用
- Clarke C, Lucisano G, Prendecki M, et al. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep. 2020. PMID: 33173838. doi:10.1016/j.ekir.2020.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。